It has long been said that “best things come in small packages” and recent scientific findings show a great example of that. People that suffer from an incredibly rare form of dwarfism called Laron syndrome seem to be completely immune to cancer, diabetes and other illnesses.
A thrilling new approach has been developed for targeted gene therapy that brought a cloud of excitement over the scientific community. You might have guessed it – the delivery of vaporized gene vectors to battle cystic fibrosis.
A lot of research universities around the world are eager to find new diagnostic and therapeutic tools with the help of nanotechnology. We could say that the founding father of this scientific field was physicist Richard P. Feynman, who in 1959 first described a process in which scientists would be able to manipulate and control individual atoms and molecules.
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. There are some forms of cancer which can be cured relatively well with known and established drugs and surgery. However, not all forms of cancer response to these approaches.
How old are you? Are you sure that’s what your body thinks?
Rejuvenation. Health and quality of life it provides. Major things we all strive for this way or the other. How do we know how old our body actually is? Does our biological age actually correlate with our chronological age?
Engineers from University of California have designed wireless sensors as small as a grain of sand which can be implanted in the body and are able to provide nerve, muscle and organ signals in real-time. They use ultrasound to power the sensors and read out their measurements.
This is no novel idea, but after 17 years of a spirited debated, pharmaceutical companies are finally taking note. It was Dr. Mary Hendrix and her team out of the University of Iowa Cancer center in Iowa City who first reported in 1999 that human melanoma tumor cells were capable of forming perfusable vessel-like networks through a process called vasculogenic mimicry (VM).
A growing global epidemic of obesity and its related health complications such as type 2 diabetes is the reason why scientists are focusing on finding genes that increase the risk of developing obesity in the last decade. A breakthrough was finally made with discovery of the gene for ‘leanness’.
The first in vivo soft tissue surgery completed by an autonomous robot is in the books, and in impressive fashion. While robots, and even autonomous robots, have been used in surgery before, they have failed to meet the high expectations set for them, especially when it comes to soft tissue. Until this study, autonomous surgical robots had only been useful for operations on solid body structures such as bone,
With all the talk about it in the scientific community, there is probably no surprise that this is yet another article discussing CRISPR. However, this may be one of the most profound discussions around the technology as it involves what could arguably be the potential flagship use of the gene editing tool – human therapy.